[Clinical pharmacology of hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000627:therapeutic use; D002306:Cardiac Volume / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011926:Rauwolfia / Q000627:therapeutic use; D014703:Veratrum / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D000319:Adrenergic beta-Antagonists; D001949:Bretylium Compounds; D004232:Diuretics; D005730:Ganglionic Blockers; D006834:Hydrazines; D007093:Imidazoles; D008996:Monoamine Oxidase Inhibitors; D008750:Methyldopa; D006145:Guanethidine
Die klinische Pharmakologie der Hypertension.